Leanne L. Seeger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Leanne L. Seeger has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
Kambiz Motamedi
Department of Radiology, Los Angeles, USA
4 shared publicationsBenjamin D. Levine
Department of Radiology, Los Angeles, USA
2 shared publications- Scott D. Nelson
University of California, Los Angeles (UCLA)
2 shared publications - Ada Braun
Amgen Inc., Thousand Oaks, CA, USA
1 shared publication - Adam J. Schwartz
Department of Orthopaedic Surgery, University of California Los Angeles Medical Center, Santa Monica, USA
1 shared publication - Amy Feng
Amgen Inc., Thousand Oaks, CA, USA
1 shared publication
Latest Publications
- Open Access
- 1 January 2023
- Published by California Digital Library (CDL) in The UCLA Radiological Science Proceedings
- Vol. 3 (2)
A Great Mimicker, Langerhans Cell Histiocytosis in a 28-Year-Old Man: A Case Report
Langerhans cell histiocytosis (LCH) is a rare myeloid neoplastic disorder typically seen in children and characterized by infiltrative bone lesions. The skin, the lungs, the liver, and the central nervous system may also be involved. Langerhans cell histiocytosis is even more unusual in adults and presents a diagnostic challenge, given that its imaging characteristics are similar to those of other, more prevalent neoplastic processes. We report a case of LCH in a 28-year-old man with neurologic symptoms due to a nonspecific suprasellar mass and a single lytic lesion in the right bony pelvis. The results of histologic evaluation of the lytic lesion confirmed the diagnosis of LCH.
- 1 January 2023
- Published by California Digital Library (CDL) in The UCLA Radiological Science Proceedings
- Vol. 3 (2)
Open AccessA Great Mimicker, Langerhans Cell Histiocytosis in a 28-Year-Old Man: A Case Report
Langerhans cell histiocytosis (LCH) is a rare myeloid neoplastic disorder typically seen in children and characterized by infiltrative bone lesions. The skin, the lungs, the liver, and the central nervous system may also be involved. Langerhans cell histiocytosis is even more unusual in adults and presents a diagnostic challenge, given that its imaging characteristics are similar to those of other, more prevalent neoplastic processes. We report a case of LCH in a 28-year-old man with neurologic symptoms due to a nonspecific suprasellar mass and a single lytic lesion in the right bony pelvis. The results of histologic evaluation of the lytic lesion confirmed the diagnosis of LCH.
- Open Access
- 11 June 2019
- Published by Springer Nature in Cureus
- Vol. 11 (6) , e4887
A Rare Anatomical Variant of Unilateral Piriformis Muscle Agenesis: A Case Report
Anatomical variation of neuromuscular structures of the gluteal region is common. The piriformis muscle, in particular, has an important relationship with the sciatic nerve and may be associated with distinct clinical conditions. We report an incidental finding of unilateral piriformis muscle agenesis diagnosed on computed tomography and magnetic resonance imaging, a rare anatomical variant of the gluteal region.
- 11 June 2019
- Published by Springer Nature in Cureus
- Vol. 11 (6) , e4887
Open AccessA Rare Anatomical Variant of Unilateral Piriformis Muscle Agenesis: A Case Report
Anatomical variation of neuromuscular structures of the gluteal region is common. The piriformis muscle, in particular, has an important relationship with the sciatic nerve and may be associated with distinct clinical conditions. We report an incidental finding of unilateral piriformis muscle agenesis diagnosed on computed tomography and magnetic resonance imaging, a rare anatomical variant of the gluteal region.
- Open Access
- 7 January 2019
- Published by Springer Nature in Skeletal Radiology
- Vol. 48 (4) , 499-501
Revisiting tract seeding and compartmental anatomy for percutaneous image-guided musculoskeletal biopsies
- 7 January 2019
- Published by Springer Nature in Skeletal Radiology
- Vol. 48 (4) , 499-501
Open AccessRevisiting tract seeding and compartmental anatomy for percutaneous image-guided musculoskeletal biopsies
- Open Access
- 27 December 2018
- Published by Springer Nature in Cureus
- Vol. 10 (12) , e3784
Intraneural Hemangioma: Case Report of a Rare Tibial Nerve Lesion
An intraneural hemangioma is a rare, benign mesodermal lesion. We present a case of a three-year-old female with the inability to straighten her right knee and fullness over the right popliteal fossa for one year. Magnetic resonance imaging (MRI) demonstrated a T2 hyperintense lesion of the popliteal fossa, within the tibial nerve. The patient underwent an uncomplicated right knee excisional biopsy, which confirmed the diagnosis of an intraneural hemangioma. Although rare, an intraneural hemangioma should be considered in the differential diagnosis of a soft tissue lesion located in the expected course of a peripheral nerve.
- 27 December 2018
- Published by Springer Nature in Cureus
- Vol. 10 (12) , e3784
Open AccessIntraneural Hemangioma: Case Report of a Rare Tibial Nerve Lesion
An intraneural hemangioma is a rare, benign mesodermal lesion. We present a case of a three-year-old female with the inability to straighten her right knee and fullness over the right popliteal fossa for one year. Magnetic resonance imaging (MRI) demonstrated a T2 hyperintense lesion of the popliteal fossa, within the tibial nerve. The patient underwent an uncomplicated right knee excisional biopsy, which confirmed the diagnosis of an intraneural hemangioma. Although rare, an intraneural hemangioma should be considered in the differential diagnosis of a soft tissue lesion located in the expected course of a peripheral nerve.
- Open Access
- 19 September 2018
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 16 (1) , 1-9
Assessment of denosumab treatment effects and imaging response in patients with giant cell tumor of bone
Denosumab has been shown to reduce tumor size and progression, reform mineralized bone, and increase intralesional bone density in patients with giant cell tumor of bone (GCTB); however, radiologic assessment of tumors in bone is challenging. The study objective was to assess tumor response to denosumab using three different imaging parameters in a prespecified analysis in patients with GCTB from two phase 2 studies. The studies enrolled adults and adolescents (skeletally mature and at least 12 years of age) with radiographically measurable GCTB that were given denosumab 120 mg every 4 weeks, with additional doses on days 8 and 15 of cycle 1. The proportion of patients with an objective tumor response was assessed using either Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST), European Organisation for Research and Treatment of Cancer response criteria (positron emission tomography [PET] scan criteria), or inverse Choi density/size (ICDS) criteria. Target lesions were measured by computed tomography or magnetic resonance imaging (both studies), PET (study 2 only), or plain film radiograph (study 2 only). Most patients (71.6%) had an objective tumor response by at least one response criteria. Per RECIST, 25.1% of patients had a response; per PET scan criteria, 96.2% had a response; per ICDS, 76.1% had a response. 68.5% had an objective tumor response ≥ 24 weeks. Using any criteria, crude incidence of response ranged from 56% (vertebrae/skull) to 91% (lung/soft tissue), and 98.2% had tumor control ≥ 24 weeks. Reduced PET avidity appeared to be an early sign of response to denosumab treatment. Modified PET scan criteria and ICDS criteria indicate that most patients show responses and higher benefit rates than modified RECIST, and therefore may be useful for early assessment of response to denosumab. ClinicalTrials.gov Clinical Trials Registry NCT00396279 (retrospectively registered November 6, 2006) and NCT00680992 (retrospectively registered May 20, 2008).
- 19 September 2018
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 16 (1) , 1-9
Open AccessAssessment of denosumab treatment effects and imaging response in patients with giant cell tumor of bone
Denosumab has been shown to reduce tumor size and progression, reform mineralized bone, and increase intralesional bone density in patients with giant cell tumor of bone (GCTB); however, radiologic assessment of tumors in bone is challenging. The study objective was to assess tumor response to denosumab using three different imaging parameters in a prespecified analysis in patients with GCTB from two phase 2 studies. The studies enrolled adults and adolescents (skeletally mature and at least 12 years of age) with radiographically measurable GCTB that were given denosumab 120 mg every 4 weeks, with additional doses on days 8 and 15 of cycle 1. The proportion of patients with an objective tumor response was assessed using either Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST), European Organisation for Research and Treatment of Cancer response criteria (positron emission tomography [PET] scan criteria), or inverse Choi density/size (ICDS) criteria. Target lesions were measured by computed tomography or magnetic resonance imaging (both studies), PET (study 2 only), or plain film radiograph (study 2 only). Most patients (71.6%) had an objective tumor response by at least one response criteria. Per RECIST, 25.1% of patients had a response; per PET scan criteria, 96.2% had a response; per ICDS, 76.1% had a response. 68.5% had an objective tumor response ≥ 24 weeks. Using any criteria, crude incidence of response ranged from 56% (vertebrae/skull) to 91% (lung/soft tissue), and 98.2% had tumor control ≥ 24 weeks. Reduced PET avidity appeared to be an early sign of response to denosumab treatment. Modified PET scan criteria and ICDS criteria indicate that most patients show responses and higher benefit rates than modified RECIST, and therefore may be useful for early assessment of response to denosumab. ClinicalTrials.gov Clinical Trials Registry NCT00396279 (retrospectively registered November 6, 2006) and NCT00680992 (retrospectively registered May 20, 2008).
- 7 December 2013
- Published by Springer Nature in Skeletal Radiology
- Vol. 43 (2) , 209-212
Intra-articular calcifications following arthroscopic ACL reconstruction: prevalence and possible significance
Purpose The goal of our study was to determine the frequency of intra-articular calcifications on initial postoperative radiographs following arthroscopic ACL reconstruction, describe their appearance, hypothesize their etiology, and determine their significance. Materials and methods Review of records and post-operative radiographs for individuals undergoing arthroscopic ACL reconstruction at our institution identified 758 knees between November 2002 and April 2010. All patients underwent femoral and tibial tunnel drilling regardless of graft source. All but 23 underwent notchplasty. Results Intra-articular calcifications on initial postoperative radiographs were observed in 252 knees. The majority of calcifications were curvilinear, paralleling the posterior femoral condyles. Nineteen of the patients with calcifications on initial studies had repeat radiographs within 6 years. The calcifications resolved in every case. Conclusions This study shows that intra-articular calcifications are a common finding on initial post-operative radiographs following ACL reconstruction. We feel they are of doubtful clinical significance, and in our limited experience, they eventually resolve. They should not be confused with chondrocalcinosis or vascular calcification.
- 7 December 2013
- Published by Springer Nature in Skeletal Radiology
- Vol. 43 (2) , 209-212
Intra-articular calcifications following arthroscopic ACL reconstruction: prevalence and possible significance
Purpose The goal of our study was to determine the frequency of intra-articular calcifications on initial postoperative radiographs following arthroscopic ACL reconstruction, describe their appearance, hypothesize their etiology, and determine their significance. Materials and methods Review of records and post-operative radiographs for individuals undergoing arthroscopic ACL reconstruction at our institution identified 758 knees between November 2002 and April 2010. All patients underwent femoral and tibial tunnel drilling regardless of graft source. All but 23 underwent notchplasty. Results Intra-articular calcifications on initial postoperative radiographs were observed in 252 knees. The majority of calcifications were curvilinear, paralleling the posterior femoral condyles. Nineteen of the patients with calcifications on initial studies had repeat radiographs within 6 years. The calcifications resolved in every case. Conclusions This study shows that intra-articular calcifications are a common finding on initial post-operative radiographs following ACL reconstruction. We feel they are of doubtful clinical significance, and in our limited experience, they eventually resolve. They should not be confused with chondrocalcinosis or vascular calcification.
- 1 August 2011
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 197 (2) , 457-461
Revisiting CT-Guided Percutaneous Core Needle Biopsy of Musculoskeletal Lesions: Contributors to Biopsy Success
OBJECTIVE. The purpose of this article is to investigate potential technical, imaging, and histopathologic contributors to the success of CT biopsy. MATERIALS AND METHODS. Four hundred forty-four consecutive CT biopsies of musculoskeletal lesions performed from 2005 to 2008 were retrospectively classified as diagnostic or nondiagnostic and as accurate or inaccurate. A biopsy was considered as diagnostic if it provided a definitive pathologic diagnosis or was clinically useful; as accurate if it was concordant with the ultimate diagnosis with respect to identification of malignancy, grade, and histopathologic features; and as successful if it was both diagnostic and accurate. Biopsy success rate, diagnostic yield, and accuracy were assessed according to lesion location, use of sedation, biopsy equipment type, bone lesion matrix type, and lesion histologic type (i.e., bone or soft-tissue origin, malignant or benign neoplasm, and lowor intermediate-to-high-grade neoplasm). RESULTS. Of 444 biopsies, 71% were ...
- 1 August 2011
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 197 (2) , 457-461
Revisiting CT-Guided Percutaneous Core Needle Biopsy of Musculoskeletal Lesions: Contributors to Biopsy Success
OBJECTIVE. The purpose of this article is to investigate potential technical, imaging, and histopathologic contributors to the success of CT biopsy. MATERIALS AND METHODS. Four hundred forty-four consecutive CT biopsies of musculoskeletal lesions performed from 2005 to 2008 were retrospectively classified as diagnostic or nondiagnostic and as accurate or inaccurate. A biopsy was considered as diagnostic if it provided a definitive pathologic diagnosis or was clinically useful; as accurate if it was concordant with the ultimate diagnosis with respect to identification of malignancy, grade, and histopathologic features; and as successful if it was both diagnostic and accurate. Biopsy success rate, diagnostic yield, and accuracy were assessed according to lesion location, use of sedation, biopsy equipment type, bone lesion matrix type, and lesion histologic type (i.e., bone or soft-tissue origin, malignant or benign neoplasm, and lowor intermediate-to-high-grade neoplasm). RESULTS. Of 444 biopsies, 71% were ...
- 1 March 2010
- Vol. 39 (3) , E28-32
Chronic sclerosing osteomyelitis treated with wide resection and vascularized fibular autograft: a case report.
Treatment recommendations for chronic culture-negative sclerosing osteomyelitis in the pediatric population have largely focused on supportive care, given the typical improvement in symptoms that occurs over time. This case report describes a patient with chronic sclerosing osteomyelitis (CSO) of the humerus who failed a prolonged course of nonoperative management. Definitive treatment consisted of resection of the diseased bone and reconstruction using a vascularized fibular osteocutaneous flap. To our knowledge, this is the first reported case of this technique being utilized specifically for CSO refractory to nonoperative management. At the time of most recent follow-up (35 months), the patient was completely pain-free and off all medication. Physical examination revealed full unrestricted passive and active range of motion. Radiographs at the time of most recent follow-up revealed intact hardware, excellent proximal and distal graft incorporation, and cortical hypertrophy. Vascularized fibular osteocutaneous flap reconstruction following resection is a viable alternative to nonoperative, expectant management for patients with refractory chronic sclerosing osteomyelitis.
- 1 March 2010
- Vol. 39 (3) , E28-32
Chronic sclerosing osteomyelitis treated with wide resection and vascularized fibular autograft: a case report.
Treatment recommendations for chronic culture-negative sclerosing osteomyelitis in the pediatric population have largely focused on supportive care, given the typical improvement in symptoms that occurs over time. This case report describes a patient with chronic sclerosing osteomyelitis (CSO) of the humerus who failed a prolonged course of nonoperative management. Definitive treatment consisted of resection of the diseased bone and reconstruction using a vascularized fibular osteocutaneous flap. To our knowledge, this is the first reported case of this technique being utilized specifically for CSO refractory to nonoperative management. At the time of most recent follow-up (35 months), the patient was completely pain-free and off all medication. Physical examination revealed full unrestricted passive and active range of motion. Radiographs at the time of most recent follow-up revealed intact hardware, excellent proximal and distal graft incorporation, and cortical hypertrophy. Vascularized fibular osteocutaneous flap reconstruction following resection is a viable alternative to nonoperative, expectant management for patients with refractory chronic sclerosing osteomyelitis.
- 1 July 2009
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 193 (1) , 5-13
CT of Rib Lesions
OBJECTIVE. This article discusses how ribs are involved in a variety of traumatic, metabolic, inflammatory, neoplastic, and congenital disorders.CONCLUSION. We review the normal anatomy pertinent to rib imaging and illustrate the key features of a variety of rib lesions, emphasizing the diagnostic value of CT.
- 1 July 2009
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 193 (1) , 5-13
CT of Rib Lesions
OBJECTIVE. This article discusses how ribs are involved in a variety of traumatic, metabolic, inflammatory, neoplastic, and congenital disorders.CONCLUSION. We review the normal anatomy pertinent to rib imaging and illustrate the key features of a variety of rib lesions, emphasizing the diagnostic value of CT.
- 1 September 2006
- Published by Springer Nature in Skeletal Radiology
- Vol. 35 (9) , 684-686
Tophaceous gout of the first costochondral junction in a heart transplant patient
We report the case of a 49-year-old man with a 10-year history of gout, who presented with a painful left first costochondral junction mass. A computed tomography (CT)-guided biopsy of the mass revealed foreign body giant cell reaction and crystalline deposition consistent with tophaceous gout.
- 1 September 2006
- Published by Springer Nature in Skeletal Radiology
- Vol. 35 (9) , 684-686
Tophaceous gout of the first costochondral junction in a heart transplant patient
We report the case of a 49-year-old man with a 10-year history of gout, who presented with a painful left first costochondral junction mass. A computed tomography (CT)-guided biopsy of the mass revealed foreign body giant cell reaction and crystalline deposition consistent with tophaceous gout.